217 related articles for article (PubMed ID: 18983664)
21. N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent.
Cho H; Kim WJ; Lee YM; Kim YM; Kwon YG; Park YS; Choi EY; Kim KW
Oncol Rep; 2004 Jan; 11(1):191-5. PubMed ID: 14654925
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium derived factor make low molecular weight heparin-endostatin and polyethylene glycol-endostatin potential candidates for anti-angiogenesis drug.
Tan H; Mu G; Zhu W; Liu J; Wang F
Biol Pharm Bull; 2011; 34(4):545-50. PubMed ID: 21467643
[TBL] [Abstract][Full Text] [Related]
23. E-selectin is required for the antiangiogenic activity of endostatin.
Yu Y; Moulton KS; Khan MK; Vineberg S; Boye E; Davis VM; O'Donnell PE; Bischoff J; Milstone DS
Proc Natl Acad Sci U S A; 2004 May; 101(21):8005-10. PubMed ID: 15148373
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization of neostatins, the MMP-derived, enzymatic cleavage products of type XVIII collagen.
Chang JH; Javier JA; Chang GY; Oliveira HB; Azar DT
FEBS Lett; 2005 Jul; 579(17):3601-6. PubMed ID: 15978592
[TBL] [Abstract][Full Text] [Related]
25. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing.
Bloch W; Huggel K; Sasaki T; Grose R; Bugnon P; Addicks K; Timpl R; Werner S
FASEB J; 2000 Dec; 14(15):2373-6. PubMed ID: 11024009
[TBL] [Abstract][Full Text] [Related]
26. Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors.
Thomas JP; Arzoomanian RZ; Alberti D; Marnocha R; Lee F; Friedl A; Tutsch K; Dresen A; Geiger P; Pluda J; Fogler W; Schiller JH; Wilding G
J Clin Oncol; 2003 Jan; 21(2):223-31. PubMed ID: 12525513
[TBL] [Abstract][Full Text] [Related]
27. Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo.
Cattaneo MG; Pola S; Francescato P; Chillemi F; Vicentini LM
Exp Cell Res; 2003 Feb; 283(2):230-6. PubMed ID: 12581742
[TBL] [Abstract][Full Text] [Related]
28. Endostatin reduces vascularization, blood flow, and growth in a rat gliosarcoma.
Sorensen DR; Read TA; Porwol T; Olsen BR; Timpl R; Sasaki T; Iversen PO; Benestad HB; Sim BK; Bjerkvig R
Neuro Oncol; 2002 Jan; 4(1):1-8. PubMed ID: 11772427
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of full-length human endostatin on in vitro angiogenesis.
Taddei L; Chiarugi P; Brogelli L; Cirri P; Magnelli L; Raugei G; Ziche M; Granger HJ; Chiarugi V; Ramponi G
Biochem Biophys Res Commun; 1999 Sep; 263(2):340-5. PubMed ID: 10491294
[TBL] [Abstract][Full Text] [Related]
30. Opposite effects of endostatin on different endothelial cells.
Schmidt A; Addicks K; Bloch W
Cancer Biol Ther; 2004 Nov; 3(11):1162-6; discussion 1167-8. PubMed ID: 15640622
[TBL] [Abstract][Full Text] [Related]
31. Increased levels of tissue endostatin in human malignant gliomas.
Morimoto T; Aoyagi M; Tamaki M; Yoshino Y; Hori H; Duan L; Yano T; Shibata M; Ohno K; Hirakawa K; Yamaguchi N
Clin Cancer Res; 2002 Sep; 8(9):2933-8. PubMed ID: 12231538
[TBL] [Abstract][Full Text] [Related]
32. Endostatin influences endothelial morphology via the activated ERK1/2-kinase endothelial morphology and signal transduction.
Schmidt A; Wenzel D; Thorey I; Sasaki T; Hescheler J; Timpl R; Addicks K; Werner S; Fleischmann BK; Bloch W
Microvasc Res; 2006 May; 71(3):152-62. PubMed ID: 16650878
[TBL] [Abstract][Full Text] [Related]
33. Endostatin affects osteoblast behavior in vitro, but collagen XVIII/endostatin is not essential for skeletal development in vivo.
Sipola A; Seppinen L; Pihlajaniemi T; Tuukkanen J
Calcif Tissue Int; 2009 Nov; 85(5):412-20. PubMed ID: 19763371
[TBL] [Abstract][Full Text] [Related]
34. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
Olsson AK; Johansson I; Akerud H; Einarsson B; Christofferson R; Sasaki T; Timpl R; Claesson-Welsh L
Cancer Res; 2004 Dec; 64(24):9012-7. PubMed ID: 15604266
[TBL] [Abstract][Full Text] [Related]
35. Binding of endostatin to human ovarian cancer cells inhibits cell attachment.
Yokoyama Y; Ramakrishnan S
Int J Cancer; 2007 Dec; 121(11):2402-9. PubMed ID: 17597104
[TBL] [Abstract][Full Text] [Related]
36. Impact of endostatin on bFGF-induced proliferation, migration, and matrix metalloproteinase-2 expression/secretion of bovine choroidal endothelial cells.
Wang YS; Eichler W; Friedrichs U; Yafai Y; Hoffmann S; Yasukawa T; Hui YN; Wiedemann P
Curr Eye Res; 2005 Jun; 30(6):479-89. PubMed ID: 16020281
[TBL] [Abstract][Full Text] [Related]
37. Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells.
Dkhissi F; Lu H; Soria C; Opolon P; Griscelli F; Liu H; Khattar P; Mishal Z; Perricaudet M; Li H
Hum Gene Ther; 2003 Jul; 14(10):997-1008. PubMed ID: 12869217
[TBL] [Abstract][Full Text] [Related]
38. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia down-regulates endostatin production by human microvascular endothelial cells and pericytes.
Wu P; Yonekura H; Li H; Nozaki I; Tomono Y; Naito I; Ninomiya Y; Yamamoto H
Biochem Biophys Res Commun; 2001 Nov; 288(5):1149-54. PubMed ID: 11700031
[TBL] [Abstract][Full Text] [Related]
40. Combined Anti-PLGF and Anti-Endostatin Treatments Inhibit Ocular Hemangiomas.
Jiang H; Wu X; Wang H; Huang C; Zhang L
Cell Physiol Biochem; 2015; 36(3):930-6. PubMed ID: 26088746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
